168 related articles for article (PubMed ID: 12890248)
1. Utility-adjusted analysis of the cost of palliative radiotherapy for bone metastases.
Barton MB; Jacob SA; Gebsky V
Australas Radiol; 2003 Sep; 47(3):274-8. PubMed ID: 12890248
[TBL] [Abstract][Full Text] [Related]
2. Single- versus multiple-fraction radiotherapy in patients with painful bone metastases: cost-utility analysis based on a randomized trial.
van den Hout WB; van der Linden YM; Steenland E; Wiggenraad RG; Kievit J; de Haes H; Leer JW
J Natl Cancer Inst; 2003 Feb; 95(3):222-9. PubMed ID: 12569144
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of single fraction of stereotactic body radiation therapy compared with single fraction of external beam radiation therapy for palliation of vertebral bone metastases.
Kim H; Rajagopalan MS; Beriwal S; Huq MS; Smith KJ
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):556-63. PubMed ID: 25680599
[TBL] [Abstract][Full Text] [Related]
4. Economic analysis of radiation therapy oncology group 97-14: multiple versus single fraction radiation treatment of patients with bone metastases.
Konski A; James J; Hartsell W; Leibenhaut MH; Janjan N; Curran W; Roach M; Watkins-Bruner D
Am J Clin Oncol; 2009 Aug; 32(4):423-8. PubMed ID: 19546803
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy is a cost-effective palliative treatment for patients with bone metastasis from prostate cancer.
Konski A
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1373-8. PubMed ID: 15590167
[TBL] [Abstract][Full Text] [Related]
6. Cost of palliative radiation to the bone for patients with bone metastases secondary to breast or prostate cancer.
Hess G; Barlev A; Chung K; Hill JW; Fonseca E
Radiat Oncol; 2012 Oct; 7():168. PubMed ID: 23062178
[TBL] [Abstract][Full Text] [Related]
7. [Bone metastases radiotherapy: Multi-approaches literature review].
Le Fèvre C; Antoni D; Thiéry A; Noël G
Cancer Radiother; 2018 Dec; 22(8):810-825. PubMed ID: 30001971
[TBL] [Abstract][Full Text] [Related]
8. Impact of a dedicated palliative radiation oncology service on the use of single fraction and hypofractionated radiation therapy among patients with bone metastases.
Skamene S; Agarwal I; Makar M; Krishnan M; Spektor A; Hertan L; Mouw KW; Taylor A; Noveroske Philbrick S; Balboni T
Ann Palliat Med; 2018 Apr; 7(2):186-191. PubMed ID: 29307209
[TBL] [Abstract][Full Text] [Related]
9. [Cost of radiotherapy for bone metastases in France: A monocentric retrospective study].
Le Fèvre C; Menoux I; Pin Y; Antoni D; Thiéry A; Noël G
Cancer Radiother; 2019 Feb; 23(1):1-9. PubMed ID: 30527438
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of the potential cost reductions resulting from the use of clodronate in the treatment of metastatic carcinoma of the breast to bone.
Biermann WA; Cantor RI; Fellin FM; Jakobowski J; Hopkins L; Newbold RC
Bone; 1991; 12 Suppl 1():S37-42. PubMed ID: 1720013
[TBL] [Abstract][Full Text] [Related]
11. Economic evaluation of single-fraction versus multiple-fraction palliative radiotherapy for painful bone metastases in breast, lung and prostate cancer.
Collinson L; Kvizhinadze G; Nair N; McLeod M; Blakely T
J Med Imaging Radiat Oncol; 2016 Oct; 60(5):650-660. PubMed ID: 27174870
[TBL] [Abstract][Full Text] [Related]
12. A Palliative Radiation Oncology Consult Service Reduces Total Costs During Hospitalization.
Chang S; May P; Goldstein NE; Wisnivesky J; Ricks D; Fuld D; Aldridge M; Rosenzweig K; Morrison RS; Dharmarajan KV
J Pain Symptom Manage; 2018 Jun; 55(6):1452-1458. PubMed ID: 29526611
[TBL] [Abstract][Full Text] [Related]
13. Palliative radiotherapy for skeletal metastases: cost-substitution analyses and economic impact.
Macklis R; Lasher J
J Oncol Manag; 1999; 8(2):17-22. PubMed ID: 10387551
[No Abstract] [Full Text] [Related]
14. Longitudinal Trends in Costs of Palliative Radiation for Metastatic Prostate Cancer.
Robinson TJ; Dinan MA; Li Y; Lee WR; Reed SD
J Palliat Med; 2015 Nov; 18(11):933-9. PubMed ID: 26241733
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing the use of single vs multiple fractions of palliative radiotherapy for bone metastases: a 5-year review.
Haddad P; Wong RK; Pond GR; Soban F; Williams D; McLean M; Levin W; Bezjak A
Clin Oncol (R Coll Radiol); 2005 Sep; 17(6):430-4. PubMed ID: 16149286
[TBL] [Abstract][Full Text] [Related]
16. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.
van den Hout WB; Kramer GW; Noordijk EM; Leer JW
J Natl Cancer Inst; 2006 Dec; 98(24):1786-94. PubMed ID: 17179480
[TBL] [Abstract][Full Text] [Related]
17. Cost-Utility Analysis of Single-Fraction Versus Multiple-Fraction Radiotherapy in Patients with Painful Bone Metastases: An Iranian Patient's Perspective Study.
Bayazidi Y; Keshtkaran A; Homaie Rad E; Ansari M; Javanbakht M; Hashemi Meshkini A; Nikfar S; Zaboli P
Value Health Reg Issues; 2017 May; 12():84-89. PubMed ID: 28648321
[TBL] [Abstract][Full Text] [Related]
18. Palliative radiotherapy for painful bone metastases from solid tumors delivered with static ports of tomotherapy (TomoDirect): feasibility and clinical results.
Franco P; Migliaccio F; Angelini V; Cante D; Sciacero P; Peruzzo Cornetto A; Casanova Borca V; Zeverino M; Torielli P; Arrichiello C; Girelli G; La Porta MR; Tofani S; Numico G; Ricardi U
Cancer Invest; 2014 Nov; 32(9):458-63. PubMed ID: 25259607
[TBL] [Abstract][Full Text] [Related]
19. Palliation of bone metastases: a survey of patterns of practice among Canadian radiation oncologists.
Chow E; Danjoux C; Wong R; Szumacher E; Franssen E; Fung K; Finkelstein J; Andersson L; Connolly R
Radiother Oncol; 2000 Sep; 56(3):305-14. PubMed ID: 10974379
[TBL] [Abstract][Full Text] [Related]
20. Radiation therapy in the management of symptomatic bone metastases: the effect of total dose and histology on pain relief and response duration.
Arcangeli G; Giovinazzo G; Saracino B; D'Angelo L; Giannarelli D; Arcangeli G; Micheli A
Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1119-26. PubMed ID: 9869238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
